<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: maintenance therapy</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Weekly and biweekly vitamin D2 prevents vitamin D deficiency</title>
   	 <description>Boston University School of Medicine researchers (BUSM) have found that 50,000 International Units (IU) of vitamin D2, given weekly for eight weeks, effectively treats vitamin D deficiency. Vitamin D2 is a mainstay for the prevention and treatment of vitamin D deficiency in children and adults. Continued treatment with the same dose of vitamin D2 every other week for up to six years after the initial eight-week period prevents vitamin D deficiency from recurring with no toxicity. The BUSM study appears online in the journal Archives of Internal Medicine.</description>
     <link>http://www.physorg.com/news175792987.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 26 Oct 2009 16:26:14 EST</pubDate>
	 <guid isPermaLink="false">news175792987</guid>
</item>
<item>
     <title>Studies show children can complete treatment for peanut allergies and achieve long-term tolerance</title>
   	 <description>A carefully administered daily dose of peanuts has been so successful as a therapy for peanut allergies that a select group of children is now off treatment and eating peanuts daily, report doctors at Duke University Medical Center and Arkansas Children's Hospital.</description>
     <link>http://www.physorg.com/news156349642.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 15 Mar 2009 15:27:59 EST</pubDate>
	 <guid isPermaLink="false">news156349642</guid>
</item>
<item>
     <title>Treatment for advanced hepatitis C doesn't work, researchers find</title>
   	 <description>An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment. In addition, the study showed a surprising health decline in patients with liver disease over the course of four years.</description>
     <link>http://www.physorg.com/news147551365.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 03 Dec 2008 18:29:25 EST</pubDate>
	 <guid isPermaLink="false">news147551365</guid>
</item>


</channel>
</rss>

